XML 60 R47.htm IDEA: XBRL DOCUMENT v3.20.4
Derivative Instruments and Hedging Activities - Derivatives in Statements of Operations (Details) - USD ($)
$ in Millions
3 Months Ended
Jan. 31, 2021
Jan. 26, 2020
Derivative Instruments, Gain (Loss) [Line Items]    
Net Sales $ 5,162 $ 4,162
Cost of products sold 2,813 2,304
Research, development and engineering 606 552
Interest expense 61 59
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations (4) 1
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations (1) 2
Foreign exchange contracts | Sales    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations (4) (1)
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations 0 2
Foreign exchange contracts | Cost of products sold    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations 2 2
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations (1) 0
Foreign exchange contracts | Research, development and engineering    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations 1 1
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations 0 0
Interest rate contracts | Interest expense    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of Gain or (Loss) Reclassified from AOCI into Consolidated Condensed Statement of Operations (3) (1)
Amount of Gain (Loss) Excluded from Effectiveness Testing Recognized in Consolidated Condensed Statement of Operations $ 0 $ 0